Am.  Jour.  Pharm.  ) 
January,  1920.  j 
Editorial, 
3 
The  Pharmacopoeial  Convention  to  be  held  in  Washington  in 
May,  to  prepare  for  the  Tenth  Decennial  Revision  of  the  United 
States  Pharmacopoeia,  will  open  to  the  medical,  pharmaceutical  and 
chemical  professions  many  avenues  for  investigation  and  altruistic 
service.  This  should  be  the  opening  opportunity  for  marking  the 
great  progress  in  the  medical  professions  during  the  decade  that 
has  passed  since  the  previous  Pharmacopoeial  Convention  convened. 
Every  pharmacist  should  be  in  alignment  with  and  participate  in  the 
work  of  the  revisions  of  the  Pharmacopoeia  and  National  Formulary 
that  will  be  commenced  in  1920. 
To  our  readers  and  friends  we  extend  BEST  WISHES  and 
HEARTY  GREETINGS  and  express  the  hope  that  the  year  1920  will 
bring  to  them  a  bounteous  measure  of  Prosperity  and  Happiness. 
G.  M.  B. 
THE  BAYER  COMPANY  CITED  TO  APPEAR  BEFORE 
THE  FEDERAI.  TRADE  COMMISSION. 
In  the  August,  19 19,  issue  of  this  JournaIv,  in  an  editorial  on  the 
"Proprieties  of  Advertising,"  reference  was  made  to  the  objectionable 
style  of  newspaper  advertising  employed  by  The  Bayer  Company  in 
advertising  aspirin  tablets  and  to  the  action  taken  by  the  Pennsyl- 
vania Pharmaceutical  Association  at  its  annual  meeting  in  condem- 
nation of  same. 
In  this  editorial,  comment  was  likewise  made  upon  the  reply  of 
The  Bayer  Company  to  the  Pennsylvania  Association,  admitting 
error  in  the  advertisement  complained  of  and  its  discontinuance  was 
announced.  We  directed  attention  to  the  fact  that,  although  this 
admission  of  error  was  not  as  frank  as  might  be  wished,  it  was  to  be 
hoped  that  under  the  new  management  of  this  Company  the  ques- 
tionable methods  of  advertising  adopted  by  its  Hun  predecessor 
would  be  discontinued  and  that  the  modern  standard  of  business 
ethics  and  the  proprieties  of  advertising  would  be  observed  in  the 
future. 
We  have  since  observed  that  this  company  has  continued  the 
extensive  campaign  of  newspaper  advertisements  of  aspirin  tablets, 
and  that  many  of  these  contain  insinuations  of  the  inferior  quality 
of  the  products  of  other  manufacturers. 
The  Federal  Trade  Commission  has  taken  cognizance  of  this 
unfair  method  of  advertising  and  formal  complaint  has  been  made 
alleging  unfair  methods  of  competition  and  The  Bayer  Company  havS 
